These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 6971418)

  • 1. [Controlled study of unspecific cellular immunity in cancer patients].
    Dominioni L; Dionigi R; Prati U; Cividini F; Cincera M; Pavesi L; Della Cuna GR
    Minerva Med; 1981 Mar; 72(12):733-40. PubMed ID: 6971418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative immunologic monitoring of cancer patients undergoing radical surgery.
    Dominioni L; Dionigi R; Zonta A; Prati U
    Boll Ist Sieroter Milan; 1978 Nov; 57(5):612-22. PubMed ID: 314812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical evaluation of lymphocyte functions in urological cancer patients.
    Elhilali MM; Paika KD; Brosman S; Fahey JL
    Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of nonspecific cell-mediated immunity in cancer patients. I. Frequent dissociation between the responses of skin tests to recall antigens and in vitro lymphocyte transformation.
    Simmler MC; Rameau G; Chou MJ; Mathé G
    Isr J Med Sci; 1976; 12(4-5):472-8. PubMed ID: 939695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assays of immunocompetence in the staging and prognosis of cancer.
    Robinson JC
    Surg Gynecol Obstet; 1981 Dec; 153(6):909-21. PubMed ID: 7029761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative cell mediated immune response is better preserved after laparoscopic vs open colorectal resection in humans.
    Whelan RL; Franklin M; Holubar SD; Donahue J; Fowler R; Munger C; Doorman J; Balli JE; Glass J; Gonzalez JJ; Bessler M; Xie H; Treat M
    Surg Endosc; 2003 Jun; 17(6):972-8. PubMed ID: 12640542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of T- and B-lymphocytes in peripheral blood of patients with solid tumours. I. Relation to other parameters of in vivo and in vitro immune competence.
    Harris J; Stewart T; Sengar DP; Hyslop D
    Can Med Assoc J; 1975 Apr; 112(8):948-52. PubMed ID: 1079472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective cell-mediated immunity in carcinoma of the prostate.
    Thomas JW; Jerkins G; Cox C; Lieberman P
    Invest Urol; 1976 Jul; 14(1):72-5. PubMed ID: 60303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some parameters of cell-mediated immunity in colon cancer patients.
    Markova R; Argirova R; Boeva M
    Neoplasma; 1980; 27(1):43-6. PubMed ID: 6966380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
    Libánský J; Lukásová M; Pinosová I
    Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
    [No Abstract]   [Full Text] [Related]  

  • 11. [Delayed-type skin reaction in children with malignant diseases].
    Ebell W; Schmidt C; Wahn V; Göbel U
    Klin Padiatr; 1985; 197(6):447-52. PubMed ID: 4087824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed cutaneous hypersensitivity and lymphocyte transformation: dissociation in atopic dermatitis.
    Elliott ST; Hanifin JM
    Arch Dermatol; 1979 Jan; 115(1):36-9. PubMed ID: 367287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical usefulness of Multitest in the evaluation of cellular immunity].
    Feijoó RM; Ardiles A; Lemp P; King A; Villamán JJ; Parra A; Silva M
    Rev Med Chil; 1996 Mar; 124(3):327-36. PubMed ID: 9008945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic defects in lung cancer patients.
    Holmes EC; Golub SH
    J Thorac Cardiovasc Surg; 1976 Feb; 71(2):161-8. PubMed ID: 1107678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
    Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro cell-mediated immunity in tuberculous meningitis.
    El-Naggar AK; Higashi GI
    J Clin Lab Immunol; 1982 May; 8(1):37-42. PubMed ID: 7047745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cellular immunity indices in benign breast tumors].
    Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
    Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological monitoring of brain tumors--prognosis based on T-lymphocyte subpopulations and skin testing for delayed hypersensitivity].
    Yokoyama H; Nakadai M; Asou Y; Maeda T; Ogashiwa M; Takeuchi K
    No To Shinkei; 1985 Feb; 37(2):193-9. PubMed ID: 3873952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic aspects of malignant tumors.
    Ariyan S
    Clin Plast Surg; 1979 Apr; 6(2):125-142. PubMed ID: 313868
    [No Abstract]   [Full Text] [Related]  

  • 20. [Features of cellular immunity of chronic lympholeukemia].
    Sinitsina AM; Zverkova AS
    Vrach Delo; 1982; (10):49-51. PubMed ID: 6983781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.